Although outcomes have improved, children with high-risk neuroblastoma continue to face high mortality1,2 

Infographic showing statistics on neuroblastoma outcomes.
OS, overall survival.
A family of 3 sitting in child'a room reading a book. The son is sitting on the mother's lap and the father is kneeling beside them.

References:

  1. 1. Sholler GLS, Ferguson W, Bergendahl G, et al. Maintenance DFMO increases survival in high risk neuroblastoma. Sci Rep. 2018;8(1):14445. doi:10.1038/s41598-018-32659-w
  2. 2. Shohet JM, Lowas SR, Nuchtern JG. Treatment and prognosis of neuroblastoma. Wolters Kluwer. UpToDate.com. Accessed December 15, 2023. Available at: https://www.uptodate.com/contents/treatment-and-prognosis-of-neuroblastoma
  3. 3. Batth IS, Dao L, Satelli A, et al. Cell surface vimentin positive circulating tumor cell-based relapse prediction in a long-term longitudinal study of post-remission neuroblastoma patients. Int J Cancer. 2020;147(12):3550-3559. doi:10.1002/ijc.33140
  4. 4. London WB, Bagatell R, Weigel BJ, et al. Historical time to disease progression and progression-free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children’s Oncology Group early-phase trials. Cancer. 2017;123:4914-4923
  5. 5. Medicine.net. Life Expectancy of Neuroblastoma: Survival Rate & Prognosis. Accessed December 15, 2023. Available at: https://www.medicinenet.com/life_expectancy_of_a_child_with_neuroblastoma/article.html